AzTrials
AzTrials

Family DynamicsDFG IINCT06322511

Dialogical Family Guidance PostDoc Study

A study testing Dialogical Family Guidance (DFG) in people with Family Dynamics and Family Relations, run by Tampere University at 1 site in Finland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This new family intervention, called Dialogical Family Guidance (DFG) is developed to target family needs especially in families with a child with neurodevelopmental disorders. PhD study showed, that this intervention is functioning with this target group. Read more about this study

Who is it for?
Ages 4 to 13 years
Conditions the study is for
Family Dynamics, Family Relations, Family Support
What is being tested?
Dialogical Family Guidance (DFG)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteFinland
Study dates
2 Jan 2024to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Families with a child with clinical diagnosis within neurodevelopmental ambrella (ADHD, Tourette, Autism disorder, OCD...).
  • the child must be between 4-13 years.

Who cannot join

  • Families who do not understand finnish language (because they can not fill the questionnaires and professionals offering DFG are all finnish speaking). At least one parent needs to talk finnish.
  • Families who are not motivated to receive DFG.
  • Families who do not have a child with neurodevelopmental disorders.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Diana Cavonius-Rintahaka, PhD contact

+358 405551511

diana.cavonius@gmail.com

Anna Liisa Aho, PhD contact

+358 401901448

annaliisa.aho@tuni.fi

Finland1 site, 1 recruiting
  • Helsinki university hospital

    Helsinki, 00029

    Recruiting

Other trials in Finland

About this study

Official title: The Effectiveness of Dialogical Family Guidance in Families With a Child With Neurodevelopmental Disorders

This new family intervention, called Dialogical Family Guidance (DFG) is developed to target family needs especially in families with a child with neurodevelopmental disorders. PhD study showed, that this intervention is functioning with this target group. Participants (families) experienced that they got information, guidance to ordinary life and that the DFG-therapists were listening to them and above all, helping with individual problems and questions. DFG include six meetings and professionals need to attend on a 3-day long education before using this intervention.

Read the detailed description

Previous studies have highlighted the need for families with a child with neurodevelopmental disorders, to get guidance to daily life, information and also professionals who allow parents to share their own experiences, feelings and questions. Dialogical Family Guidance is developed to offer target families (participants) the help mentioned above. This study is a postdoctoral study to achieve more knowledge and understanding about DFG intervention. This Postdoctoral study is focusing on DFG effectivity offered to families with young children (5-7years). Researchers also want to receive information about DFG effectivity between different units inside and outside the university hospital. Comparation between different units using DFG is one goal with this postdoc study. These results may give researchers deeper understanding when deciding where (university hospital och basic level units) and for whom (childrens age?) DFG intervention is giving the most optimal help.

Being tested
Dialogical Family Guidance (DFG)
Keywords
neurodevelopmental disorders, family health, family functionality, family support
Medical subject headings
Neurodevelopmental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dialogical Family Guidance (DFG)Behavioural

    DFG is family intervention including six meetings with family members. The individual needs and questions of each family are discussed and issues parents bring up are seemed as important.

Study groups in NCT06322511
Study groupRoleWhat they receive
Intervention groupExperimentalThese families receive Dialogical family guidance, including six meetings (during 3 months) within the intervention manual proceedings. Parents fill the questionnaires before and after the intervention.
Receives: Behavioral: Dialogical Family Guidance (DFG)
comparative groupNo interventionThese families (parents in the family) give responses how they manage in ordinary life with their child with neurodevelopmental disorders. These families do not receive the intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. FAFHES

    FAFHES (Family Function, Health, and Social Support-questionnaire). The name of the questionnaire explains the content of this questionnaire that includes three sections: family functionality (19 items), family health (23 items), family support provided by professionals (21 items). Likert scale is used with ranging from 1-6 (1= disagree totally......6=I agree totally).

    Measured: 0 months and 3 months

Secondary outcomes (2)
  1. DFG-questionnaire

    This questionnaire has been developed for DFG intervention including questions about the intervention sessions and themes. Items are included: e.g. questions about the amount and time consumed on DFG, content as a whole, practical advances, did your family get help, would you recommend this to other families. Likert scale from 1-5 is used. Two open ended questions in the end of the questionnaire is included.

    Measured: 3 months

  2. SDQ-p questionnaire (Strengths and difficulties regarding the child)

    Measures changes in child's behavior. Includes 25 items with 3 point likert scale.

    Measured: 0 months and 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2024
  2. Study start2 Jan 2024
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Families attending the study Group I: receives Dialogical Family Guidance intervention and they fill questionnaires before and after the intervention. Group II: Families do not receive Dialogical Family Guidance (but belong to the same focus group)
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06322511
Sponsor's protocol ID
HUS/7626/2023
Acronym
DFG II
Status last verified
Mar 2024
First submitted
7 Mar 2024
Last updated
21 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: No information is shared regarding the families attending the study. Analyzed study results are shared by using results from scientific study protocols published in academic and international publications.

Questions about this trial

What is this clinical trial studying?

A study testing Dialogical Family Guidance (DFG) in people with Family Dynamics and Family Relations, run by Tampere University at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Diana Cavonius-Rintahaka, PhD (+358 405551511, diana.cavonius@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

FAFHES (time frame: 0 months and 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in